1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Piquin Y Sabores Distributors LLC - 733360 - 07/02/2026
  1. Warning Letters

WARNING LETTER

Piquin Y Sabores Distributors LLC MARCS-CMS 733360 —

Delivery Method:
Via Express Delivery
Product:
Food & Beverages
Recipient:
Recipient Name
Leonardo Torres
Recipient Title
Owner
Piquin Y Sabores Distributors LLC

2002 Platinum St.
Garland, TX 75042-6661
United States

piquinysaboresdistributor@gmail.com
Issuing Office:
Office of Inspections and Investigations

United States

07/02/2026

WARNING LETTER

Re: CMS # 733360

Dear Mr. Leonardo Torres,

On September 25, 2024, the Food and Drug Administration (FDA) conducted a Foreign Supplier Verification Program (FSVP) inspection of Piquin Y Sabores Distributors LLC located at 2002 Platinum St. Garland TX 75042-6661. We also conducted an inspection on June 04, 2026. These inspections were conducted to determine compliance with the requirements of section 805 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 384a) and the implementing FSVP regulation in 21 CFR part 1, subpart L

The FSVP regulation requires that importers perform certain risk-based activities to verify that human and/or animal food they import into the United States has been produced in a manner that meets applicable U.S. food safety standards. You may find information relating to the FSVP regulation and your responsibilities to comply with the regulation through links in FDA’s FSVP web page at https://www.fda.gov/food/food-safety-modernization-act-fsma/fsma-final-rule-foreign-supplier-verification-programs-fsvp-importers-food-humans-and-animals.

During the most recent inspection, we found that you are not in compliance with the requirements of 21 CFR part 1, subpart L for the foods from the foreign suppliers indicated in the attached list. Because of these significant violations, you are not in compliance with section 805 of the FD&C Act.

At the conclusion of the inspection, our investigator provided you with a Form FDA 483a FSVP Observations.

We acknowledge receipt of your response, dated June 25, 2026, in which you stated your firm will stop importing from some foreign suppliers, including (b)(4) from (b)(4). We are unable to evaluate the adequacy of your response because you have not provided any supporting documentation demonstrating your corrective actions. To date, no additional FSVP documents have been received by FDA

Your significant violations of the FSVP regulation are as follows:

You did not develop, maintain, and follow an FSVP as required by section 805 of the FD&C Act and 21 CFR 1.502(a). Specifically, you did not develop an FSVP for the foods you import from the foreign suppliers indicated in the attached list, including each of the following foods:

  • Corn Chips, imported from, (b)(4), located in (b)(4)
  • Granola, imported from, (b)(4), located in (b)(4)

The above violations are not intended to be an all-inclusive list of violations of the FSVP requirements. It is your responsibility to ensure that you are in compliance with section 805 of the FD&C Act and the implementing regulation in 21 CFR part 1, subpart L.

This letter notifies you of our concerns and provides you an opportunity to address them. If you do not adequately address this matter, we may take further action. For instance, we may take action under section 801(a)(3) of the FD&C Act (21 U.S.C. 381(a)(3)) to refuse admission of the food you import for which you appear to be in violation of section 805. We may place [the foods you import into the United States -or- the food[s] from the identified foreign supplier[s] on detention without physical examination (DWPE) when you import the foods. You can find DWPE information relating to FSVP in Import Alert # 99-41 at http://www.accessdata.fda.gov/cms_ia/ialist.html. In addition, the importation or offering for importation into the United States of an article of food without the importer having an FSVP that meets the requirements of section 805 of the FD&C Act or the FSVP regulation is prohibited under section 301(zz) of the FD&C Act (21 U.S.C. 331(zz)).

You should respond in writing within fifteen (15) working days from your receipt of this letter. Your response should address the specific things you are doing to correct any violations. You should include in your response documentation and information that would assist us in evaluating your corrections (e.g., documentation of changes you made, such as a copy of your FSVP, records to demonstrate implementation of your FSVP), and any additional information that you wish to supply relevant to your compliance with the FSVP regulation. If you believe that you are not in violation of the FD&C Act, include your reasoning and any supporting information for our consideration. If you cannot complete all corrections within 15 working days, you should explain the reason for your delay and state when you will correct any remaining violations.

Please send your reply to Food and Drug Administration, Attention: Peter D. Cavazos, Compliance Officer, Division of Southwest Imports, 216 West Village Blvd, Suite 107 Lareod, TX 78041. If you have any questions regarding this letter, or wish to send your response electronically, you may contact Peter D. Cavazos via email at peter.cavazos@fda.hhs.gov. Please reference CMS # 733360 on any documents or records you provide to us and on the subject line of any email correspondence you send to us.

Sincerely,
/S/

Stacy Below
Acting Program Division Director
Division of Southwest Imports
1201 Main Street, Suite 7200
Dallas, TX 75202

Back to Top